Prosus Leads €480 Million Investment in French Health Tech Startup Alan French health-tech startup Alan has secured one of Europe’s biggest non-AI funding rounds this year, underscoring how digital healthcare is drawing major capital even amid an AI-dominated investment climate.

In the run-up to the deal, Dutch-listed investment group Prosus had been actively scouting high-growth European technology companies, with specialist coverage highlighting ongoing “news, analysis and opinion on Prosus” and its sector bets in areas such as fintech and online services. This backdrop set the stage for a move into health technology, where digital insurance and virtual care platforms have been gaining traction across Europe.

On 24 June 2026, Prosus led a €480 million investment in Alan, a Paris-based health-tech company that provides digital-first health insurance and employee benefits solutions. The Paris group’s fundraising was described as “one of Europe’s biggest non-AI start-up rounds this year,” signalling strong investor confidence in health-tech business models that do not rely primarily on frontier AI.

From Prosus’s perspective, the round aligns with its broader strategy of backing technology platforms with large addressable markets and recurring revenues. Coverage of the investor frames the deal as part of a pattern in which “Prosus” targets fast-growing digital service providers around the world, now extending that approach to European healthcare infrastructure.

From Alan’s side, the company is expected to use the fresh capital to accelerate product development and expand its footprint beyond France, according to reporting that the infusion “is expected to fuel Alan’s growth and expansion efforts.” The size of the round may also enhance Alan’s ability to compete with incumbent insurers and newer digital rivals across Europe.

Analysts note that, taken together, Prosus’s leadership in this €480 million round and Alan’s growth ambitions position the deal as a bellwether for how non-AI tech sectors—particularly health-tech—can still command blockbuster funding in an increasingly AI-focused investment landscape.

Continue reading https://foxvector.com/stories/019efc1a-843e-1dc5-7240-1b79b3184398